Skip to content

Advertisement

Open Peer Review Reports for: Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
18 Jul 2016 Submitted Original manuscript
31 Jan 2017 Reviewed Reviewer Report - Rotraud Wieser
17 May 2017 Reviewed Reviewer Report - Lars Bullinger
17 Jun 2017 Author responded Author comments - Håkon Reikvam
Resubmission - Version 2
17 Jun 2017 Submitted Manuscript version 2
21 Jun 2017 Reviewed Reviewer Report - Rotraud Wieser
2 Jul 2017 Reviewed Reviewer Report - Lars Bullinger
9 Aug 2017 Author responded Author comments - Håkon Reikvam
Resubmission - Version 3
9 Aug 2017 Submitted Manuscript version 3
24 Aug 2017 Author responded Author comments - Håkon Reikvam
Resubmission - Version 4
24 Aug 2017 Submitted Manuscript version 4
Publishing
28 Aug 2017 Editorially accepted
6 Sep 2017 Article published 10.1186/s12885-017-3620-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement